<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> is an autosomal dominantly inherited disorder caused by germline mutations in DNA mismatch repair (MMR) genes </plain></SENT>
<SENT sid="1" pm="."><plain>Previous studies have shown that MMR gene mutation carriers are at increased risk of colorectal, endometrial, and several other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> following an initial diagnosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We estimated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risks following an <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> diagnosis for women carrying MMR gene mutations </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We obtained data from the <z:hpo ids='HP_0003003'>Colon Cancer</z:hpo> Family Registry for a cohort of 127 women who had a diagnosis of <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> and who carried a mutation in one of four MMR genes (30 carried a mutation in MLH1, 72 in MSH2, 22 in MSH6, and 3 in PMS2) </plain></SENT>
<SENT sid="4" pm="."><plain>We used the Kaplan-Meier method to estimate 10- and 20-year cumulative risks for each <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>We estimated the age-, country-, and calendar period-specific standardized incidence ratios (SIRs) for each <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, compared with the general population </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Following <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e>, women carrying MMR gene mutations had the following 20-year risks of other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (48%, 95% confidence interval [CI] = 35% to 62%); <z:e sem="disease" ids="C0740457" disease_type="Neoplastic Process" abbrv="">cancer of the kidney</z:e>, renal pelvis, or ureter (11%, 95% CI = 3% to 20%); <z:e sem="disease" ids="C0699885,C0005684" disease_type="Neoplastic Process" abbrv="">urinary bladder cancer</z:e> (9%, 95% CI = 2% to 17%); and <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (11%, 95% CI = 4% to 19%) </plain></SENT>
<SENT sid="7" pm="."><plain>Compared with the general population, these women were at statistically significantly elevated risks of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (SIR = 39.9, 95% CI = 27.2 to 58.3), <z:e sem="disease" ids="C0740457" disease_type="Neoplastic Process" abbrv="">cancer of the kidney</z:e>, renal pelvis, or ureter (SIR = 28.3, 95% CI = 11.9 to 48.6), <z:e sem="disease" ids="C0699885,C0005684" disease_type="Neoplastic Process" abbrv="">urinary bladder cancer</z:e> (SIR = 24.3, 95% CI = 8.56 to 42.9), and <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (SIR = 2.51, 95% CI = 1.17 to 4.14) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Women with <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> who are diagnosed with <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> have increased risks of several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, including <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
</text></document>